SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-006142
Filing Date
2024-04-29
Accepted
2024-04-29 17:04:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240429xdefa14a.htm DEFA14A 16112
2 GRAPHIC tmb-20240429xdefa14a_bg001.jpg GRAPHIC 192490
  Complete submission text file 0001558370-24-006142.txt   282410
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38650 | Film No.: 24892400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)